Trial intelligence / Profile preview

Dexmedetomidine for postoperative hypertension after laparotomy

IRCT20150217021121N3Phase 3Completed

Sponsor
Tabriz University of Medical Sciences
Start
Aug 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of dexmedetomidine in hypertension (HTN) (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: blood pressure, pain and 1 more. Started Aug 2017; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on IRCT20150217021121N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20150217021121N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call